Overview

Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide

Status:
Completed

Trial end date:
2018-02-12

Target enrollment:

Participant gender:

Summary

Defibrotide is an anti-inflammatory and anti-coagulatory agent approved for treatment of veno-occlusive disease. Although it has been in clinical use for almost 30 years, the exact mechanism of action has never been fully elucidated. Thus, the effects of defibrotide will be investigated in the human endotoxemia model in order to gather further information on its actions.

Phase:

Phase 4

Details

Lead Sponsor:

Bernd Jilma

Treatments:

Defibrotide